Particulate delivery systems for vaccines

what can we expect?

Vincent W. Bramwell, Yvonne Perrie

Research output: Contribution to journalArticle

Abstract

In our attempts to thwart the unwanted attentions of microbes by prophylactic and therapeutic vaccination, the knowledge of interactions at the molecular level may prove to be an invaluable asset. This article examines how particulate delivery systems such as liposomes and polymer microspheres can be applied in the light of recent advances in immunological understanding. Some of the biological interactions of these delivery systems are discussed with relevance for antigen trafficking and molecular pathways of immunogenicity and emphasis on the possible interaction of liposomal components. In particular, traditional concepts such as antigen protection, delivery to antigen presenting cells and depot formation remain important aspects, whilst the inclusion of selected co-adjuvants and enhanced delivery of these moieties in conjunction with antigen now has a firm rationale. © 2006 The Authors.

Original languageEnglish
Pages (from-to)717-728
Number of pages12
JournalJournal of Pharmacy and Pharmacology
Volume58
Issue number6
DOIs
Publication statusPublished - Jun 2006

Fingerprint

Vaccines
Antigens
Antigen-Presenting Cells
Microspheres
Liposomes
Polymers
Vaccination
Therapeutics

Cite this

Bramwell, Vincent W. ; Perrie, Yvonne. / Particulate delivery systems for vaccines : what can we expect?. In: Journal of Pharmacy and Pharmacology. 2006 ; Vol. 58, No. 6. pp. 717-728.
@article{4e84f35129ec4efe97a83c4738839e6e,
title = "Particulate delivery systems for vaccines: what can we expect?",
abstract = "In our attempts to thwart the unwanted attentions of microbes by prophylactic and therapeutic vaccination, the knowledge of interactions at the molecular level may prove to be an invaluable asset. This article examines how particulate delivery systems such as liposomes and polymer microspheres can be applied in the light of recent advances in immunological understanding. Some of the biological interactions of these delivery systems are discussed with relevance for antigen trafficking and molecular pathways of immunogenicity and emphasis on the possible interaction of liposomal components. In particular, traditional concepts such as antigen protection, delivery to antigen presenting cells and depot formation remain important aspects, whilst the inclusion of selected co-adjuvants and enhanced delivery of these moieties in conjunction with antigen now has a firm rationale. {\circledC} 2006 The Authors.",
author = "Bramwell, {Vincent W.} and Yvonne Perrie",
year = "2006",
month = "6",
doi = "10.1211/jpp.58.6.0002",
language = "English",
volume = "58",
pages = "717--728",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "6",

}

Particulate delivery systems for vaccines : what can we expect? / Bramwell, Vincent W.; Perrie, Yvonne.

In: Journal of Pharmacy and Pharmacology, Vol. 58, No. 6, 06.2006, p. 717-728.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Particulate delivery systems for vaccines

T2 - what can we expect?

AU - Bramwell, Vincent W.

AU - Perrie, Yvonne

PY - 2006/6

Y1 - 2006/6

N2 - In our attempts to thwart the unwanted attentions of microbes by prophylactic and therapeutic vaccination, the knowledge of interactions at the molecular level may prove to be an invaluable asset. This article examines how particulate delivery systems such as liposomes and polymer microspheres can be applied in the light of recent advances in immunological understanding. Some of the biological interactions of these delivery systems are discussed with relevance for antigen trafficking and molecular pathways of immunogenicity and emphasis on the possible interaction of liposomal components. In particular, traditional concepts such as antigen protection, delivery to antigen presenting cells and depot formation remain important aspects, whilst the inclusion of selected co-adjuvants and enhanced delivery of these moieties in conjunction with antigen now has a firm rationale. © 2006 The Authors.

AB - In our attempts to thwart the unwanted attentions of microbes by prophylactic and therapeutic vaccination, the knowledge of interactions at the molecular level may prove to be an invaluable asset. This article examines how particulate delivery systems such as liposomes and polymer microspheres can be applied in the light of recent advances in immunological understanding. Some of the biological interactions of these delivery systems are discussed with relevance for antigen trafficking and molecular pathways of immunogenicity and emphasis on the possible interaction of liposomal components. In particular, traditional concepts such as antigen protection, delivery to antigen presenting cells and depot formation remain important aspects, whilst the inclusion of selected co-adjuvants and enhanced delivery of these moieties in conjunction with antigen now has a firm rationale. © 2006 The Authors.

UR - http://www.scopus.com/inward/record.url?scp=33744791458&partnerID=8YFLogxK

UR - http://onlinelibrary.wiley.com/doi/10.1211/jpp.58.6.0002/abstract

U2 - 10.1211/jpp.58.6.0002

DO - 10.1211/jpp.58.6.0002

M3 - Article

VL - 58

SP - 717

EP - 728

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 6

ER -